George Mason University
George Mason University Researchers Developing Urine-Based Lyme Disease Test With $1.2M Army Grant
Premium
The researchers will use a $1.2 million US Department of the Army grant to support studies on the detection of Borrelia proteins in patients' urine samples.
HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
The funding is being provided to 10 groups through the LymeX Diagnostics Prize initiative, which was launched in late 2020 by theHHS- and Cohen Foundation-backed Lyme Innovation Accelerator.
Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test
The test, developed at George Mason, measures HER2 activation in a breast cancer biopsy to help determine if a patient will respond to treatment.
Fluidigm CEO Chris Linthwaite said the company aims to further penetrate the diagnostic and clinical markets with both its microfluidics and mass cytometry businesses.
Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth
The firm also announced a COVID-19 testing deal with George Mason University and a CyTOF supply and distribution agreement with Zhejiang PuLuoTing Health Technology in China.